Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Amicomed is a digital health company, now a brand of Newel Health, that provides a CE-marked Software as a Medical Device (SaMD) for hypertension management. The platform uses proprietary algorithms to analyze blood pressure trends and variability, offering users personalized lifestyle interventions and clinical insights. By bridging the gap between doctor visits, Amicomed empowers patients to monitor their cardiovascular health and adhere to non-pharmacological treatments. The solution is validated by clinical data showing significant reductions in systolic blood pressure and is designed for integration into healthcare provider workflows and insurance models.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Amicomed.